101 related articles for article (PubMed ID: 22532260)
1. Joint hypermobility syndrome: a risk factor for fixed dystonia?
Kassavetis P; Batla A; Pareés I; Saifee TA; Schrag A; Cordivari C; Bhatia KP; Edwards MJ
Mov Disord; 2012 Jul; 27(8):1070. PubMed ID: 22532260
[No Abstract] [Full Text] [Related]
2. Immediate response to botulinum toxin injections in patients with fixed dystonia.
Edwards MJ; Bhatia KP; Cordivari C
Mov Disord; 2011 Apr; 26(5):917-8. PubMed ID: 21394784
[No Abstract] [Full Text] [Related]
3. The clinical syndrome of primary tic disorder associated with dystonia: a large clinical series and a review of the literature.
Damásio J; Edwards MJ; Alonso-Canovas A; Schwingenschuh P; Kägi G; Bhatia KP
Mov Disord; 2011 Mar; 26(4):679-84. PubMed ID: 21506147
[TBL] [Abstract][Full Text] [Related]
4. Medical therapy and botulinum toxin in dystonia.
Jankovic J
Adv Neurol; 1998; 78():169-83. PubMed ID: 9750914
[No Abstract] [Full Text] [Related]
5. Case studies in movement disorders.
Evidente VG; Caviness JN; Adler CH
Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
Whitaker J; Butler A; Semlyen JK; Barnes MP
Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
[TBL] [Abstract][Full Text] [Related]
7. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien CF
Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
[No Abstract] [Full Text] [Related]
8. [Repetitive non-instrumental use dystonia].
Vercueil L
Rev Neurol (Paris); 2009 Jan; 165(1):92-3; author reply 94. PubMed ID: 19084248
[No Abstract] [Full Text] [Related]
9. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
[TBL] [Abstract][Full Text] [Related]
10. [Laryngeal dystonia].
Barbosa ER
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):829. PubMed ID: 11593295
[No Abstract] [Full Text] [Related]
11. [Idiopathic focal dystonia of the foot in a 98-year-old-woman. Treatment with botulin toxin].
Verlhac B; Dobigny-Roman N; Forette B
Presse Med; 1996 Dec; 25(40):2042. PubMed ID: 9082380
[No Abstract] [Full Text] [Related]
12. Delayed-onset focal dystonia of the leg secondary to traumatic brain injury.
Kemp S; Kim SD; Cordato DJ; Fung VS
J Clin Neurosci; 2012 Jun; 19(6):916-7. PubMed ID: 22341145
[TBL] [Abstract][Full Text] [Related]
13. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
[TBL] [Abstract][Full Text] [Related]
14. Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and dystonia.
Black KJ; Racette B; Perlmutter JS
Am J Psychiatry; 1998 Sep; 155(9):1298-9. PubMed ID: 9734560
[No Abstract] [Full Text] [Related]
15. [Dystonia: their epidemiology, aetiology, diagnosis and treatment].
Rodríguez-Constela I; Rodríguez-Regal A; Cebrián-Pérez EM
Rev Neurol; 2009 Jan; 48 Suppl 1():S61-9. PubMed ID: 19222018
[TBL] [Abstract][Full Text] [Related]
16. Pain in ehlers-danlos syndrome is common, severe, and associated with functional impairment.
Voermans NC; Knoop H; Bleijenberg G; van Engelen BG
J Pain Symptom Manage; 2010 Sep; 40(3):370-8. PubMed ID: 20579833
[TBL] [Abstract][Full Text] [Related]
17. [Ehlers-Danlos and dystonia. Positive effects of amantadine].
Hamonet C; Césaro P
Presse Med; 2014 Sep; 43(9):1017-8. PubMed ID: 24814364
[No Abstract] [Full Text] [Related]
18. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
Hennings JM; Krause E; Bötzel K; Wetter TC
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
[TBL] [Abstract][Full Text] [Related]
19. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
Gudex CM; Hawthorne MR; Butler AG; Duffey P
Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
Panicker JN; Muthane UB
Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
